Advertisement
Australia markets closed
  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     
  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     
  • AUD/USD

    0.6488
    -0.0001 (-0.02%)
     
  • OIL

    82.86
    -0.50 (-0.60%)
     
  • GOLD

    2,337.50
    -4.60 (-0.20%)
     
  • Bitcoin AUD

    99,209.04
    -3,611.66 (-3.51%)
     
  • CMC Crypto 200

    1,398.77
    -25.33 (-1.78%)
     
  • AUD/EUR

    0.6070
    +0.0014 (+0.23%)
     
  • AUD/NZD

    1.0949
    +0.0019 (+0.18%)
     
  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     
  • NASDAQ

    17,445.41
    -26.06 (-0.15%)
     
  • FTSE

    8,040.38
    -4.43 (-0.06%)
     
  • Dow Jones

    38,353.17
    -150.52 (-0.39%)
     
  • DAX

    18,088.70
    -48.95 (-0.27%)
     
  • Hang Seng

    17,201.27
    +372.34 (+2.21%)
     
  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     

Why InnovAge Stock Dived by 11% Today

Why InnovAge Stock Dived by 11% Today

InnovAge (NASDAQ: INNV) is one company that will be very glad to see 2021 consigned to the history books. On Monday, the company's stock fell by 11%, on the back of two recommendation downgrades from prominent investment banks. The catalyst for the downgrades was InnovAge's disclosure last week that it had been hit with sanctions from the Centers for Medicare and Medicaid Services (CMS).